ACS

Featured Article

Infection and Infarction: Cause and Effect?

Infection and Infarction: Cause and Effect?

Investigators sought to confirm long-standing hypotheses that acute infections can lead to myocardial infarction.

Latest Features

Infection and Infarction: Cause and Effect?

Infection and Infarction: Cause and Effect?

Investigators sought to confirm long-standing hypotheses that acute infections can lead to myocardial infarction.

The Uncertain Association Between Abacavir and the Risk for Acute Myocardial Infarction

The Uncertain Association Between Abacavir and the Risk for Acute Myocardial Infarction

A higher prevalence of traditional cardiovascular risk factors may be partially responsible for the increased incidence of cardiovascular disease in people living with HIV.

Benefits of Inpatient Smoking Cessation Therapy Post-Myocardial Infarction

Benefits of Inpatient Smoking Cessation Therapy Post-Myocardial Infarction

Hospitals may be missing opportunities to start tobacco use treatment immediately after myocardial infarction.

Cardiac Rehabilitation: Changes, Challenges, and Clinician Perspectives

Cardiac Rehabilitation: Changes, Challenges, and Clinician Perspectives

An overview of cardiac rehabilitation use plus interviews with Monica Mukherjee, MD, MPH, FACC, FASE and with Jonathan Ledyard, MS, RCEP.

Assessing Chest Pain in ER With Short-term Risk Stratification Tool

Assessing Chest Pain in ER With Short-term Risk Stratification Tool

The HEART Score is a safe risk-stratification tool for chest pain, but it does not seem to do much for reducing hospital utilization and admissions.

Oxygen Therapy for Acute MI: Best Practice or Harmful Treatment?

Oxygen Therapy for Acute MI: Best Practice or Harmful Treatment?

Evidence is lacking to support oxygen therapy for acute myocardial infarction.

PCSK9 Inhibitor Alirocumab Associated With 75% Reduction in Apheresis

PCSK9 Inhibitor Alirocumab Associated With 75% Reduction in Apheresis

Among patients with heterozygous familial hypercholesterolemia, alirocumab was associated with a 75% reduction in lipoprotein apheresis compared with placebo.

Bioresorbable Stents Promising But Metal Stents Still Have Role in Coronary Intervention

Bioresorbable Stents Promising But Metal Stents Still Have Role in Coronary Intervention

Experts say bioresorbable stents are "a few generations away" from being standard of care in interventional cardiology.

Deferred Stenting or Ischemic Postconditioning in STEMI Patients Did Not Reduce Adverse Events

Deferred Stenting or Ischemic Postconditioning in STEMI Patients Did Not Reduce Adverse Events

A composite end point of death, heart failure, new myocardial infarction, and revascularization was similar between the deferred stenting group and the conventional treatment group.

Room for Improvement: Pharmacologic Management of Acute Coronary Syndromes

Room for Improvement: Pharmacologic Management of Acute Coronary Syndromes

Poor adherence to dual antiplatelet therapy plays a significant role in outcomes for patients with acute coronary syndromes.

Latest News

Income Drops and Volatility Linked With Cardiovascular Events and Mortality

Income Drops and Volatility Linked With Cardiovascular Events and Mortality

The risk for cardiovascular disease and all-cause mortality have been correlated with income drops and volatility.

Statin Therapy Often Not Initiated Before First Acute Coronary Syndrome Event

Statin Therapy Often Not Initiated Before First Acute Coronary Syndrome Event

Data on adherence to the 2013 ACA/AHA cholesterol guidelines suggest significant underuse of appropriate-intensity statin therapy; however, data for statin use in primary prevention have been limited.

Co-Payment Vouchers Increase P2Y12 Inhibitor Persistence in Patients With MI

Co-Payment Vouchers Increase P2Y12 Inhibitor Persistence in Patients With MI

Researchers examined the effect of a co-payment voucher to offset medication payment costs on continual P2Y12 inhibitor use and on risk for major adverse cardiovascular events at 1 year in adult patients with myocardial infarction discharged with prescriptions for clopidogrel or ticagrelor.

Guideline-Based Statin Therapy Often Not Initiated Before First ACS Event

Guideline-Based Statin Therapy Often Not Initiated Before First ACS Event

Data on adherence to the 2013 ACA/AHA cholesterol guidelines suggest significant underuse of appropriate-intensity statin therapy; however, data for statin use in primary prevention have been limited.

How Has the Medicaid Expansion Affected Patients Hospitalized With Acute MI?

How Has the Medicaid Expansion Affected Patients Hospitalized With Acute MI?

While recent Medicaid expansion has reduced uninsured rates among patients with AMI, it has not improved quality of care or patient outcomes.

Cardiac Troponin Elevation Predicts Major Adverse Events Even Without Specific Diagnosis

Cardiac Troponin Elevation Predicts Major Adverse Events Even Without Specific Diagnosis

Elevation of serum cardiac troponin on hospital admission is predictive of major adverse events even when no specific diagnosis is established.

High-Intensity Statins Affect Coronary Plaque Composition After STEMI

High-Intensity Statins Affect Coronary Plaque Composition After STEMI

Patients using a high-intensity statin after a STEMI experienced a significant increase in minimum fibrous cap thickness.

What Is the Optimal Revascularization Strategy in Patients With Cerebrovascular Disease?

What Is the Optimal Revascularization Strategy in Patients With Cerebrovascular Disease?

Data from the EXCEL trial do not currently support a preferential role for PCI as opposed to CABG in patients with prior cerebrovascular disease.

Peripheral Artery Disease: Incidence and Outcomes of Myocardial Infarction

Peripheral Artery Disease: Incidence and Outcomes of Myocardial Infarction

Myocardial infarction was associated with an increased risk of cardiovascular death and acute limb ischemia in patients with peripheral artery disease.

IVUS-Guided DES Implantation Improves Clinical Outcomes in Broad Range of Patients

IVUS-Guided DES Implantation Improves Clinical Outcomes in Broad Range of Patients

IVUS-guided DES implantation resulted in a lower incidence of target-vessel failure at 12 months for patients undergoing PCI.